Northern Trust
DMK

Northern Trust’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Northern Trust’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-103,493
Closed -$72.5K – 4538
2023
Q4 		$72.5K Buy
+103,493
New +$60.1K ﹤0.01% 4167
2023
Q2 		– Sell
-3,495
Closed -$28.4K – 4607
2023
Q1 		$28.4K Hold
3,495
– – ﹤0.01% 4382
2022
Q4 		$41.4K Hold
3,495
– – ﹤0.01% 4326
2022
Q3 		$49K Hold
3,495
– – ﹤0.01% 4329
2022
Q2 		$123K Sell
3,495
-203
-5% -$6.34K ﹤0.01% 4091
2022
Q1 		$148K Hold
3,698
– – ﹤0.01% 4230
2021
Q4 		$157K Hold
3,698
– – ﹤0.01% 4285
2021
Q3 		$251K Hold
3,698
– – ﹤0.01% 4074
2021
Q2 		$285K Hold
3,698
– – ﹤0.01% 3969
2021
Q1 		$243K Buy
3,698
+1,241
+51% +$96.7K ﹤0.01% 4041
2020
Q4 		$83K Buy
2,457
+133
+6% +$5.92K ﹤0.01% 4150
2020
Q3 		$127K Sell
2,324
-136
-6% -$8.06K ﹤0.01% 3910
2020
Q2 		$92K Buy
2,460
+876
+55% +$30K ﹤0.01% 3941
2020
Q1 		$40K Hold
1,584
– – ﹤0.01% 3988
2019
Q4 		$78K Hold
1,584
– – ﹤0.01% 3978
2019
Q3 		$78K Buy
1,584
+321
+25% +$23.1K ﹤0.01% 3969
2019
Q2 		$115K Hold
1,263
– – ﹤0.01% 3944
2019
Q1 		$187K Sell
1,263
-1,111
-47% -$215K ﹤0.01% 3795
2018
Q4 		$373K Sell
2,374
-49
-2% -$9.39K ﹤0.01% 3622
2018
Q3 		$594K Buy
2,423
+480
+25% +$114K ﹤0.01% 3602
2018
Q2 		$435K Sell
1,943
-50
-3% -$13.4K ﹤0.01% 3637
2018
Q1 		$489K Buy
1,993
+670
+51% +$176K ﹤0.01% 3573
2017
Q4 		$408K Buy
1,323
+529
+67% +$174K ﹤0.01% 3606
2017
Q3 		$291K Buy
794
+64
+9% +$22.7K ﹤0.01% 3686
2017
Q2 		$266K Buy
730
+38
+5% +$11.4K ﹤0.01% 3707
2017
Q1 		$206K Buy
692
+205
+42% +$51.7K ﹤0.01% 3788
2016
Q4 		$107K Buy
487
+60
+14% +$12K ﹤0.01% 3886
2016
Q3 		$102K Buy
427
+7
+2% +$1.46K ﹤0.01% 3890
2016
Q2 		$82K Sell
420
-161
-28% -$74.2K ﹤0.01% 3934
2016
Q1 		$249K Sell
581
-211
-27% -$75.4K ﹤0.01% 3656
2015
Q4 		$299K Buy
792
+59
+8% +$18.5K ﹤0.01% 3637
2015
Q3 		$199K Buy
733
+508
+226% +$141K ﹤0.01% 3749
2015
Q2 		$66K Sell
225
-47
-17% -$14.2K ﹤0.01% 4020
2015
Q1 		$75K Sell
272
-26
-9% -$11.2K ﹤0.01% 4097
2014
Q4 		$129K Hold
298
– – ﹤0.01% 3931
2014
Q3 		$98K Sell
298
-35
-11% -$10.3K ﹤0.01% 4023
2014
Q2 		$112K Buy
+333
New +$131K ﹤0.01% 3985

Other funds holding DMK

Clear Point Advisors
Clear Point Advisors Melville, New York $113M AUM 15% 1-Year Est. Return
Old Point Trust & Financial Services N A
Old Point Trust & Financial Services N A Newport News, Virginia $329M AUM 22.88% 1-Year Est. Return

Northern Trust's DMK Position: Q1 2024 in Review

Northern Trust sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 103,493 shares — an estimated $72.5K sold.

Northern Trust first reported a position in DMK in Q2 2014 and held it in 37 quarters. The position peaked at $594K in Q3 2018. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

  • Northern Trust reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
  • Northern Trust sold 103,493 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $72.5K.
  • Northern Trust first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2014 and held it in 37 quarters.
  • Northern Trust's DMK Pharmaceuticals Corporation Common Stock position peaked at $594K in Q3 2018.
  • 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.